Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$2.93M Buy
60,359
+45,330
+302% +$2.21M 0.02% 649
2023
Q4
$747K Buy
15,029
+1,775
+13% +$86.8K 0.01% 904
2023
Q3
$711K Buy
13,254
+2,648
+25% +$141K 0.01% 880
2023
Q2
$572K Buy
10,606
+363
+4% +$19.5K 0.01% 983
2023
Q1
$557K Buy
10,243
+881
+9% +$42.9K 0.01% 965
2022
Q4
$453K Buy
+9,362
New +$411K 0.01% 1031
2022
Q3
Sell
-4,763
Closed -$238K 1442
2022
Q2
$238K Buy
+4,763
New +$253K 0.01% 1145
2022
Q1
Sell
-4,155
Closed -$208K 1520
2021
Q4
$208K Sell
4,155
-165
-4% -$8.16K ﹤0.01% 1304
2021
Q3
$208K Buy
+4,320
New +$220K ﹤0.01% 1285
2020
Q2
Sell
-5,893
Closed -$258K 952
2020
Q1
$258K Buy
5,893
+380
+7% +$18.2K 0.01% 642
2019
Q4
$277K Sell
5,513
-217
-4% -$10.2K 0.01% 744
2019
Q3
$265K Sell
5,730
-1,110
-16% -$47.9K 0.01% 732
2019
Q2
$293K Buy
+6,840
New +$291K 0.01% 709
2016
Q3
Sell
-19,101
Closed -$802K 817
2016
Q2
$802K Sell
19,101
-118
-0.6% -$4.84K 0.06% 306
2016
Q1
$768K Sell
19,219
-3,750
-16% -$151K 0.06% 309
2015
Q4
$979K Hold
22,969
0.08% 269
2015
Q3
$1.08M Sell
22,969
-282
-1% -$14.4K 0.1% 216
2015
Q2
$1.15M Buy
23,251
+41
+0.2% +$2.08K 0.1% 226
2015
Q1
$1.15M Sell
23,210
-1,350
-5% -$64.5K 0.11% 220
2014
Q4
$1.12M Sell
24,560
-2,111
-8% -$102K 0.11% 220
2014
Q3
$1.5M Buy
26,671
+1,134
+4% +$60.9K 0.11% 158
2014
Q2
$1.36M Buy
+25,537
New +$1.36M 0.15% 168

Other funds holding SNY

Cetera Advisors's SNY Position: Q1 2024 in Review

Cetera Advisors increased its Sanofi (SNY) stake by 302% in Q1 2024, buying an estimated $2.21M and bringing the position to 60,359 shares worth $2.93M. The position accounts for 0.02% of the portfolio, ranked #649.

Cetera Advisors first reported a position in SNY in Q2 2014 and has held it in 22 quarters since. 713 funds tracked by Wall St. Rank hold SNY as of Q1 2024.

  • Cetera Advisors held 60,359 shares of Sanofi worth $2.93M as of Q1 2024.
  • Cetera Advisors bought 45,330 Sanofi shares in Q1 2024, an estimated $2.21M.
  • Sanofi made up 0.02% of Cetera Advisors's portfolio in Q1 2024, its #649 holding.
  • Cetera Advisors first reported a position in Sanofi in Q2 2014 and has held it in 22 quarters since.
  • 713 funds tracked by Wall St. Rank held Sanofi as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.